All Infection Prevention & Control articles – Page 10
-
NewsScientists discover why shingles pain can last after virus is gone
Researchers have discovered that small particles in the blood called exosomes are the likely culprit behind why some people with shingles experience lingering pain long after virus has cleared their body.The study investigated the cause of post-herpetic neuralgia (PHN) in patients infected with the varicella zoster virus.
-
NewsWidespread Covid death underreporting around the world raises broader questions about the reliability of official information
A new study finds that widespread underreporting of Covid-19 deaths cannot be explained simply by differences in countries’ ability to count and record deaths. Across 134 countries and territories, an estimated 45%–55% of governments misreported Covid mortality, with underreporting far more common than overreporting.
-
NewsFewer infections, more azithromycin use seen among emergency c-section patients following publication of clinical trial results
Researchers investigated if azithromycin use and postpartum infection rates changed after publication of trial evidence in 2016 among US pregnant women who underwent an unscheduled cesarean delivery.
-
NewsImmunization to prevent RSV in infants reduced ICU admissions by 97 per cent
A new immunization, offered free to all infants through universal programs in two Canadian provinces, provided strong protection against respiratory syncytial virus, commonly referred to as RSV, sharply reducing hospitalizations and intensive care unit (ICU) admissions in infants.
-
NewsThe usefulness of labelled white blood cells in diagnosing necrotizing external otitis
Using radiopharmaceutical technology, researchers can reliably and conveniently diagnose and monitor necrotizing external otitis, a rare disease of the skull base.
-
NewsStudy uncovers how mRNA vaccination may broaden flu antibody responses
A new study finds that mRNA vaccination sustained influenza-specific germinal-center activity for up to six months in some participants.
-
NewsDangerous strings of bacteria use flow to spread colonies
Researchers have identified how certain dangerous bacteria are spread. They studied chain-like adherence pattern (CLAP) varieties of Shiga toxin-producing E. coli (STEC), finding that single bacteria attach to a surface and elongate before dividing, producing chains without ever separating.
-
NewsWhat low vaccination rates in the US could mean for flu season 2026
Experts reveal what to expect this flu season, when to get the flu shot, how to recognize flu symptoms, how to treat it, and what the newly approved mRNA flu vaccine means for the public.
-
NewsThe Wistar Institute wins $15M+ NIH investment to advance HIV cure research strategies
The Wistar Institute has announced the National Institutes of Health (NIH) has awarded two major grants totaling more than $15M to Luis J. Montaner, D.V.M., D.Phil., director of Wistar’s HIV Cure and Viral Diseases Center.
-
NewsThese bacteria can change their diet to survive inside the body
The team have found that Staphylococcus aureus can adjust its diet depending on what sources remain available. The bacterium can adjust its inner workings in response to any one of a number of different sulfur-containing compounds — like cysteine, glutathione or thiosulfate.
-
NewsResearchers discover highly potent compound that blocks Ebola virus entry
A research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus’s entry protein and provides strong protection when given orally in a preclinical model. It is more than 100 times more potent than previously reported Ebola entry inhibitors.
-
NewsC. diff coordinates threat response to survive in gut
Researchers have discovered a unique system C. diff uses to simultaneously sense and respond to two different threats: host-mediated nutrient deprivation and a microbiota-produced antibiotic compound, suggesting new therapeutic options for preventing and treating C. diff infections.
-
NewsEngineering bacterial surfaces with glucan nanofilms creates a potent vaccine platform against invasive fungal infections
A research team has developed a synthetic bacterium-based vaccine platform that uses engineered bacterial surfaces to assemble glucan nanofilms for enhanced antifungal immunity against pathogens such as Candida albicans.
-
NewsA pan-sRNome analysis identifies novel regulatory small RNAs involved in Pseudomonas aeruginosa virulence
A characterization of nine newly discovered sRNAs reveals their regulatory networks in quorum sensing, biofilm formation, and interbacterial competition in Pseudomonas aeruginosa.
-
NewsExpert consensus outlines 12 recommendations to prevent secondary mucormycosis after respiratory viral infections
The recommendations focus on defined high-risk patients, early viral testing and treatment, hospital infection control, and practical measures for resource-limited settings.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsSymposium commemorating the 50th anniversary of the discovery of the Hantaan virus successfully held
A symposium commemorating the 50th anniversary of the discovery of the Hantaan virus celebrated the historical achievement of the late Dr. Lee Ho-wang and reviewed the historical significance of Hantaan virus research, its results, and future infectious disease response strategies.
-
-
NewsHelicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide
Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study - and those born in more recent decades may be more at risk of the disease after exposure.
-
NewsVaccine protects against multiple fungal infections without hurting the gut
A vaccine created to battle multiple life-threatening fungal infections is successful in achieving protective immunity in pre-clinical animal models while also maintaining the biodiversity of the gut microbiome, according to a new study.